1![January 2012 issue 84 rearranged:Layout 1 a c c e s s o u r January 2012 issue 84 rearranged:Layout 1 a c c e s s o u r](https://www.pdfsearch.io/img/c0bf641b0caff2909f1acaadb71b5964.jpg) | Add to Reading ListSource URL: www.healthwatch-uk.orgLanguage: English - Date: 2013-01-16 05:31:19
|
---|
2![Chapter 10 Laws and Regulations Affecting Unconventional Cancer Treatments
CONTENTS Chapter 10 Laws and Regulations Affecting Unconventional Cancer Treatments
CONTENTS](https://www.pdfsearch.io/img/9fb39c91c82f34b1ef08bb898c6fe290.jpg) | Add to Reading ListSource URL: www.princeton.eduLanguage: English - Date: 1996-11-21 08:14:57
|
---|
3![References
References 1. Abbott, B.J., Developmental Therapeutics Program, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human References
References 1. Abbott, B.J., Developmental Therapeutics Program, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human](https://www.pdfsearch.io/img/52754552b9f068c16cfb22ff85c7ed79.jpg) | Add to Reading ListSource URL: www.princeton.eduLanguage: English - Date: 1996-11-21 08:15:11
|
---|
4![Chapter 5 Pharmacologic and Biologic Treatments
CONTENTS Chapter 5 Pharmacologic and Biologic Treatments
CONTENTS](https://www.pdfsearch.io/img/c24d7e096a01db8f2422bdb55ff7632c.jpg) | Add to Reading ListSource URL: www.princeton.eduLanguage: English - Date: 1996-11-21 08:14:54
|
---|
5![Burzynski Research Institute Redacted 2013 Burzynski Research Institute Redacted 2013](https://www.pdfsearch.io/img/6846ddf7ed9cd72448f88ebcd3115ad7.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
6![May_7_13_PRESS_KIT_2013_no_Contact_info May_7_13_PRESS_KIT_2013_no_Contact_info](https://www.pdfsearch.io/img/37c0ff3aec6879145178b156c87c13a1.jpg) | Add to Reading ListSource URL: www.burzynskimovie.comLanguage: English - Date: 2013-07-02 06:51:43
|
---|
7![P a g e |1 Responses to January 17th to March 15th, 2013 (FDA-483) Inspectional Observations Observation 1 Failure to monitor the progress of an investigation conducted under your IND. Specifically, P a g e |1 Responses to January 17th to March 15th, 2013 (FDA-483) Inspectional Observations Observation 1 Failure to monitor the progress of an investigation conducted under your IND. Specifically,](https://www.pdfsearch.io/img/20930ab97230edaeca36a353495fb05e.jpg) | Add to Reading ListSource URL: www.burzynskiresearch.comLanguage: English - Date: 2013-11-14 10:27:36
|
---|
8![Page |1 Responses to January 7th to March 15th, 2013 (FDA-483) Inspectional Observations Observation 1 An investigation was not conducted in accordance with the signed statement of investigator and investigation plan. Sp Page |1 Responses to January 7th to March 15th, 2013 (FDA-483) Inspectional Observations Observation 1 An investigation was not conducted in accordance with the signed statement of investigator and investigation plan. Sp](https://www.pdfsearch.io/img/af4283a5f657648ab566dbfc0cde429a.jpg) | Add to Reading ListSource URL: www.burzynskiclinic.comLanguage: English - Date: 2013-11-11 18:52:45
|
---|
9![Stanislaw R Burzynski, MD Stanislaw R Burzynski, MD](https://www.pdfsearch.io/img/25a112cba33482230046a5bd3f86f196.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
10![In the Matter of the Complaint Against Stanislaw R. Burzynski MD PhD. Before the Texas State Board of Medical Examiners. Second Amended Complaint[removed].. In the Matter of the Complaint Against Stanislaw R. Burzynski MD PhD. Before the Texas State Board of Medical Examiners. Second Amended Complaint[removed]..](https://www.pdfsearch.io/img/3f6f10ff2e5c2a22168d52eb49f7fc26.jpg) | Add to Reading ListSource URL: www.bioethicswatch.org- Date: 2008-02-29 00:58:47
|
---|